Main results
Five small heterogeneous randomised controlled trials, all at high risk of performance bias and most at risk of at least one other type of bias, were included. These involved approximately 200 participants with a diagnosis of patellofemoral pain syndrome. All compared taping versus control (no or placebo taping) and all included one or more co-interventions given to both taping and control group participants; this was prescribed exercise in four trials. The intensity and length of treatment was very varied: for example, length of treatment ranged from one week in one trial to three months in another. A meta-analysis of the visual analogue scale (VAS) pain data (scale 0 to 10: worst pain), measured in different ways, from four trials (data from 161 knees), found no statistically or clinically significant difference between taping and non taping in pain at the end of the treatment programmes (mean difference (MD) -0.15; 95% confidence interval (CI) -1.15 to 0.85; random-effects model used given the significant heterogeneity (P < 0.0001)). Data for other outcomes measuring function and activities of daily living were from single trials only and gave contradictory results.
Authors' conclusions
The currently available evidence from trials reporting clinically relevant outcomes is low quality and insufficient to draw conclusions on the effects of taping, whether used on its own or as part of a treatment programme. Further research involving large, preferably multi-centre, good quality and well reported randomised controlled trials that measure clinically important outcomes and long-term results is warranted. Before this, consensus is required on the diagnosis of patellofemoral pain syndrome, the standardisation of outcome measurement and an acceptable approach for patellar taping.
P L A I N L A N G U A G E S U M M A R Y

Taping across the knee cap for adults with persistent pain at the front of the knee (patellofemoral pain)
Pain at the front of the knee (also known as anterior knee pain or patellofemoral pain) is a common problem which particularly affects those who do some form of sport or exercise. Typically, it gets worse when going up and down stairs, squatting, kneeling and sitting with the knee bent. It is a distinct and separate condition from knee arthritis.
Such anterior knee pain is often treated by physiotherapists, who use a variety of techniques. One such technique is the use of a simple piece of adhesive tape across the knee cap to control the positioning of the knee-cap (patella) and potentially reduce the pain during movement.
The review found five trials, involving around 200 participants with this condition, which compared the clinical use of taping with no taping. All five studies differed from each other in terms of the type of participants (one trial involved army recruits), length and schedule of the treatment programme and assessment of outcome. In four trials, participants of both taping and no or placebo taping groups were prescribed exercises. In part because both the therapist and the patient knew whether they were getting taping, some caution was necessary in interpreting the study results. Pooled results from four trials (161 knees) for the level of pain at the end of the treatment programme (ranging for one week to three months) showed no difference between those given taping and those not. Data for other outcomes measuring function and activities of daily living were from single trials only and gave different results.
The review concluded that the currently available evidence from trials reporting clinically relevant outcomes is and low quality and insufficient to draw conclusions on the effects of taping. However, before further trials are conducted, some consensus is required to establish the typical patients, taping technique and the best way of measuring outcome.
B A C K G R O U N D Description of the condition
Patellofemoral pain syndrome refers to the clinical presentation of knee pain related to changes in the patellofemoral joint. Patellofemoral pain syndrome usually has a gradual onset of pain with none of the features associated with other knee injuries or diseases. Authors in the United Kingdom (Anderson 2003), mainland Europe (Witvrouw 2003) , Australia (McConnell 1996) and the USA (Brechter 2002) have stated that 25% of the adult population present with patellofemoral pain at some point, but have cited data from studies involving sporting or military cohorts. As a recent population estimate for adults aged between 19 to 50 years is just over 25 million in England alone (ONS 2007) , these estimates may indicate that patellofemoral pain syndrome is a considerable health burden. However, the true prevalence and incidence of patellofemoral pain syndrome in the population as a whole remains unknown (Callaghan 2007) . Patellofemoral pain syndrome can cause functional limitations (Callaghan 1996; Callaghan 2004) . The best way to manage the condition remains controversial and treatment failure rates are reported to be high (Brown 2000) . Researchers have shown that patients may have higher than expected levels of disability (Clark 2000b ) and psychological morbidity (Jensen 2005) . A significant number may still experience symptoms many years after diagnosis (Nimon 1998) and there are concerns that the syndrome may predispose to osteoarthritis (Utting 2005). However, the possibility that anterior knee pain is a risk factor for incident patellofemoral osteoarthritis warrants further attention (Thomas 2010). The aetiology of patellofemoral pain syndrome is also unclear, with some studies suggesting that biomechanical abnormalities may be precipitated by occupation, sports or footwear (Cheung 2006). Higher body mass indices have been observed in patients with patellofemoral pain syndrome (Clark 2000b) and this apparent association cannot be ignored given the increasing prevalence of obesity in society.
Anatomical considerations for this condition
The patellofemoral joint is a complex joint arrangement between the back of the patella (knee-cap) and the reciprocally shaped distal end of the femur (thigh bone). The patella is a rounded bone embedded in the quadriceps tendon and is the largest of its kind (a sesamoid bone) in the body. Its joint surface has a large flat area on the outside, a smaller convex area on the inside, which in turn has a smaller area at its extreme, usually described as the 'odd facet' (Goodfellow 1976). The patellofemoral joint is a synovial joint and is the least stable joint in the lower limb; it has six degrees of freedom of motion and very large forces of multiple times the body weight are applied rapidly through a wide range of motion during everyday functional activities (Selfe 2010b). The primary role of the patella is to increase the efficiency and mechanical advantage of the large quadriceps muscles on the front of the thigh (Malek 1981) . It also has a role in distributing the compressive forces at the joint by increasing the contact area between patella and thigh bone. The patella provides a fulcrum for the static and dynamic stabilisation supports (Malek 1981) . The static stabilisers of the patella are a variety of ligaments, bursae (fluid sacs) and fascial tissue that keep the patella in its position in the centre of the knee. The dynamic stabilisers are muscle and tendons, the most important of which are the quadriceps muscles and, to a lesser extent, the hamstrings at the back of the thigh.
Description of the intervention
Patellar taping is an inexpensive technique readily and often used in the treatment of patients with patellofemoral pain syndrome. The technique involves the application of adhesive sports medical tape directly to the skin over the patella on the front of the knee. Usually, this tape is applied by physiotherapists during a treatment session but it can also be applied by patients at home and left on during waking hours. A variety of taping methods and techniques are in use. These include variations in the type of tape (elastic or rigid), the direction of pull of the tape (medial, lateral, inferior, superior, rotational, or no directional pull at all) and the number of layers of tape applied over the patella.
How the intervention might work
The dominant theory from both orthopaedic and physiotherapy perspectives is that most patellofemoral pain is the result of some form of patellar malalignment. But although it is purported to be present in the majority of patients with gradual, non-arthritic and non-traumatic patellar pain, the same cannot be said for adolescents who usually have patella problems related to growth and development (Grelsamer 1998). Physical correction of malalignment is just one of the reasons why patellar taping is thought to be beneficial for patellofemoral pain syndrome and there is an implication that the correction of static stability may restore normal patellar tracking by also improving dynamic stability. McConnell 1986 originally described patellar taping as part of a treatment programme for patellofemoral pain syndrome and theorised that this technique could alter patellar alignment, enhance contractions of the vastus medialis oblique (VMO) muscle, and hence decrease pain. Although these theories how a taping intervention might work were accepted for many years, subsequent studies have been contradictory regarding the ability of taping to realign patellar position (Crossley 2000) and to enhance VMO contractions (Cerny 1995b). Nevertheless, a number of studies have shown that patellar taping does decrease pain in patients with patellofemoral pain syndrome (for example, Powers 1997b), although the mechanism for this symptomatic improvement remains unknown (Callaghan 1997; Selfe 2004).
Why it is important to do this review
While the true health burden of patellofemoral pain syndrome is not known, it is common in young active adults and a source of long term disability (Clark 2000b; Nimon 1998). The best way to manage the condition is not known and treatment failures are frequent (Brown 2000). Patellar taping is commonly used in clinical practice for this condition either as a sole technique, or more commonly in conjunction with an exercise programme. We set out to systematically review the evidence for patellar taping for treating patellofemoral pain syndrome.
O B J E C T I V E S
To assess the effects, primarily on pain and function, of patellar taping for treating patellofemoral pain syndrome in adults.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials and quasi-randomised controlled trials (a method of allocating participants to a treatment that is not strictly random; i.e. by date of birth, hospital record number, or alternation) evaluating patellar taping for adults with patellofemoral pain syndrome.
Types of participants
Adults, aged 18 and above, diagnosed with patellofemoral pain syndrome. Patellofemoral pain syndrome could include other terms or synonyms associated with the condition (e.g. anterior knee pain, patella malalignment syndrome, retropatellar pain) as long as those studies had applied criteria to exclude other causes of pain not related to the patellofemoral joint. Trials that treated patients after a patella fracture, patella dislocation or subluxation or patients with a history of recurrent dislocation and subluxation were excluded. Also excluded were trials involving patients with concomitant neurological, rheumatological or cardiovascular problems.
Types of interventions
We included studies comparing any kind of patellar taping, thus where patients were randomly allocated to receive any kind of adhesive tape across the patella, versus placebo taping (i.e. tape placed across the surface of the patella without correction to patella alignment) or no taping. Patellar taping could be the only intervention or applied with other interventions, such as home exercises, as long as the same interventions were provided to the control group as well.
We excluded studies that compared patellar taping with another intervention (such as exercises) or that compared composite interventions, that included patellar taping, with no intervention or different interventions.
Types of outcome measures
We considered the following outcome measures: 1. Pain during activities or at rest
• Patient assessment scales such as (but not exclusively limited to) the visual analogue scale (VAS) and self-reported questionnaires subject and sensitive to patellofemoral pain syndrome such as the Kujala Patellofemoral Pain Score; the Functional Index Questionnaire; the Modified Functional Index Questionnaire; and other scoring systems related to the knee joint or patellofemoral pain syndrome.
Function
• Patient functional assessment scales such as (but not exclusively limited to) the visual analogue scale (VAS) and selfreported questionnaires subject and sensitive to patellofemoral pain syndrome such as the Kujala Patellofemoral Pain Score; the Functional Index Questionnaire; the Modified Functional Index Questionnaire; and other scoring systems related to the knee joint or patellofemoral pain syndrome.
Activity levels
• Patient activity assessment scales such as (but not exclusively limited to) the visual analogue scale (VAS) and selfreported questionnaires subject and sensitive to patellofemoral pain syndrome such as the Kujala Patellofemoral Pain Score; the Modified Functional Index Questionnaire (MFIQ); the Functional Index Questionnaire (FIQ); and other scoring systems related to the knee joint or patellofemoral pain syndrome.
Quality of life
• Patient quality of life assessment scales such (but not exclusively limited to) self-reported questionnaires subject and sensitive to patellofemoral pain syndrome such as the Kujala Patellofemoral Pain Score; the Functional Index Questionnaire; the Modified Functional Index Questionnaire, the Western Ontario and McMaster University Osteoarthritis Index (WOMAC); and the Medical Outcomes study short form 36 (SF-36).
Timing of outcome assessment
The time points considered are as follows. 1. Immediately after the completion of a treatment programme. 2. Preferably at least six months follow-up when taping is used as part of a treatment programme. We did not consider trials where outcome measures such EMG (electromyogram) data, gait analysis, patellar position or alignment were studied without pain evaluation. 
Search methods for identification of studies
Searching other resources
We searched reference lists of articles and contacted experts in the field in order to identify unpublished trials.
Data collection and analysis
Selection of studies
Both authors (MJC and JS) independently reviewed the title, abstract and descriptors of each paper identified from the results of the literature searches with the aim of selecting trials for the main review. We then reviewed the full text of the trials that appeared to meet the criteria. Consensus was reached between the two authors without need for third party intervention.
Data extraction and management
Both authors (MJC and JS) independently extracted trial data using a double extraction process. Details from included studies were then entered into RevMan by MJC. We made several attempts to contact trialists for additional information on trial methodology and missing data.
Assessment of risk of bias in included studies
Both authors (MJC and JS) independently assessed the risk of bias of included studies using The Cochrane Collaboration's 'Risk of bias' tool (Higgins 2008). We assessed risk of selection bias (based on an assessment of random sequence generation and allocation concealment), performance bias (based on assessment of blinding of participants and therapists administrating the treatment), detection bias (based on assessment of assessor blinding), attrition bias (based on assessment of completeness of outcome data), and 'other bias'. For 'other bias', we assessed comparability of the treatment groups at baseline, the inclusion of other care programmes for the participants, and the monitoring treatment compliance during the trial. Disagreement was resolved by consensus without recourse to third party intervention. Neither author was blinded to the authorship of studies.
Measures of treatment effect
Where available, quantitative data were presented for the outcomes listed for each trial. Mean differences and 95% confidence intervals were calculated for continuous data, and risk ratios and 95% confidence intervals were calculated for dichotomous outcome measures.
Unit of analysis issues
We did not address the potential for unit of analysis issues in our protocol. However, while the inclusion of bilateral cases in some trials is a problem, it was irresolvable because of lack of data.
Dealing with missing data
We contacted trial authors for missing data. Where data were available, we conducted intention-to-treat analyses performed but otherwise used the data as presented. There were insufficient data to conduct sensitivity analyses to explore the effects of drop outs and exclusions.
Assessment of heterogeneity
Heterogeneity between comparable trials was evaluated visually and its presence tested using the chi-squared test with a P value of < 0.1 being statistically significant. Consistency between the studies was also calculated using the I² test and larger values were considered as an indicator of substantial heterogeneity.
Data synthesis
For each study, the risk ratio (RR) and 95% confidence intervals (CI) were calculated for dichotomous outcomes and mean differences and 95% confidence intervals for continuous outcomes. While we planned to use the standardised mean difference where it was necessary to combine the results from different scales, we made an exception for pain data that could be converted for presentation on a 10 cm visual analogue scale. When there was no heterogeneity, we pooled data using the fixed-effect model. If there was significant heterogeneity, we considered pooling data using the random-effects model.
Subgroup analysis and investigation of heterogeneity
Subgroup analyses were undertaken within RevMan for trials that included an exercise co-intervention and those that did not. We were unable to conduct our two other planned subgroup analyses to investigate gender (i.e. did females gain more benefit than males from taping?) and the population studied (i.e. trials that focused on the sporting population, the military population or the general adult population). We looked at the effect on the pain results from the exclusion of the only trial testing taping on people with acute patellofemoral pain.
Sensitivity analysis
There were insufficient data to perform our planned sensitivity analyses on various aspects of trial methodology such as concealment of allocation, inclusion and exclusion criteria and accounting for missing data. We looked at the effects of analysing the data with fixed-effect and random-effects models for pain.
R E S U L T S Description of studies
See: Characteristics of included studies; Characteristics of excluded studies; Characteristics of studies awaiting classification.
Results of the search
Two hundred and eighty references were retrieved, from which 45 potentially eligible studies were identified. Of these, five studies were included, 36 were excluded and one study (Miller 2010) , which is only published as a conference abstract, is awaiting assessment. All of the fully reported potentially eligible studies were published in English language journals except for Nafstad 1996, which was in Norweigian, and Wijnen 1996, which was in Dutch. Upon translation, both these trials were excluded. 
Excluded studies
The reasons for excluding 36 studies are given in the Characteristics of excluded studies. Twenty-five studies were excluded because they only assessed the effect of patellar taping immediately post-application. Seven trials were excluded because they did not compare taping with no or placebo taping. The remaining four studies were excluded for a variety of other reasons.
Risk of bias in included studies
For more information about the risk of bias assessment, please see 
Allocation
The independent administration of pre-numbered sealed envelopes meant that Mason 2011 was considered at low risk of selection bias. There was insufficient information to determine whether allocation concealment was achieved in Clark 2000a. The other three trials were considered at high risk of selection bias, relating to lack of allocation concealment. This was retrospective in Kowall 1996, where patients consented after randomisation but no details were given as to whether any refused consent.
Blinding
A major risk of bias was that no studies were able to blind the therapists who were giving the treatment. This was a difficult area to control because by the very nature of the complex interventions used, it was generally not possible to blind the participants to 
Effects of interventions
The effects of patellar taping were assessed by the main outcome measures of pain, functional scores, activity levels and quality of life. The two comparisons (taping versus no taping, and taping plus exercise versus exercise and no taping) are presented as two subgroups. The results for the two control groups of Whittingham 2004 were combined.
Pain during activities or at rest
Various pain data from four trials are presented in Analysis 1.1 using a random-effects model given the very significant heterogeneity (mean difference (MD) -0.15; 95% confidence interval (CI) -1.15 to 0.85; heterogeneity: Chi² = 25.78, df = 4 (P < 0.0001); I² = 84%). The footnotes of Analysis 1.1 give details of the pain assessment and data for each trial. Pooled data from three of the four trials testing non-acute cases were homogeneous and also showed no significant effect, either clinical or statistical of taping on pain (see Analysis 1.2: MD 0.25; 95% CI -0.26 to 0.77). The test for subgroup differences showed no difference between the taping on its own or when used with exercises (Chi² = 1.15, df = 1 (P = 0.28), I² = 13.0%). There were no usable data from Kowall 1996, which reported that there was no difference in improvement of patellofemoral pain between the two groups at four weeks. All participants of the taping group in Whittingham 2004, which recruited people with acute knee pain, had no pain at end of treatment at four weeks. Clark 2000a found no difference between the two groups at 12 months for either comparison (see Analysis 1.3).
Function and activities of daily living
All 
D I S C U S S I O N
Summary of main results
Five small heterogeneous trials, including around 200 patients (216 knees) with a diagnosis of patellofemoral pain syndrome, were included. All compared taping versus control (no or placebo taping) and all included one or more co-interventions; this was prescribed exercise in four trials. Pooled visual analogue data from four trials (161 knees) for various measures of pain at the end of treatment (this ranged from one week to three months) showed no significant benefit from taping. Separately, two trials found better results after taping for functional index questionnaire data and Cincinnati knee activity scores. Another trial found no significant benefit for taping in WOMAC scores at the end of treatment or at 12 months. The same trial also found no benefit from taping for subsequent referral or physiotherapy.
Overall completeness and applicability of evidence
The available evidence from trials testing the clinical effects of taping is little, amounting at maximum to pooled pain data for 161 knees. Even for this 'exploratory' analysis, the heterogeneous nature of the trial populations, interventions and outcome measures (both in timing and definition) is considerable. In terms of the trial populations, there was considerable variation in the inclusion criteria and definition of patellofemoral pain syndrome among and often within the studies. The most common discrepancy was the length of time the patient had their patellofemoral pain at the time of recruitment. In one study, which involved army recruits, this was 'acute' (Whittingham 2004), whereas a lower limit of one month or more was applied for the other four studies. This means that it is possible that the patients were not comparable. Establishing inclusion and exclusion criteria for trials of patellofemoral pain syndrome will always be hampered by the lack of a gold standard diagnostic test for the condition. It remains essentially a diagnosis of exclusion reliant on description of symptoms and thorough clinical examination to exclude other causes of pain at the anterior part of the knee which are not directly related to the patellofemoral joint. Additionally, our focus was on non-arthritic patellofemoral pain but inclusion of patients with patellofemoral osteoarthritis was permitted by Mason 2011 and was likely given the older population and the long duration of symptoms (up to 15 years) in some patients. The interventions also varied as did the co-interventions (e.g. exercise, education, ice). Some studies described in detail the method of taping used, including the technique and also the type of taping (e.g. Mason 2011), whereas others gave no description (e.g.
Tunay 2003
). There are anyway insufficient data to assess if there are differences in effect between a complex taping technique and a simple one. The frequency and intensity of taping (and co-interventions) also varied. Mason 2011, which compared taping versus control for one week only before moving onto a composite treatment, commented that "the objective improvement over such a short time period was unexpected". Whittingham 2004 found complete recovery from an acute episode after four weeks in the group given taping, and good improvement too (perhaps reflecting the advice to stop certain activities) in the two control groups. This reflects also the variation in the trial populations, but also links with the assessment of outcome, which was mainly at the end of the treatment programmes. Only Clark 2000a followed up trial participants subsequently. One finding of this review was the disappointing lack of standardisation of even a simple outcome measure such as the visual analogue score for pain. This highlights an important methodological issue for future researchers into patellofemoral pain in general and the use of patellar taping in particular. Adopting a valid, reliable and standardised pain score is the obvious aim, but true standardisation is hampered by the fact that patients may declare different pain inducing activities when they use the visual analogue score. These activities usually include stair ascent or descent, squatting, kneeling and prolonged sitting. There was no comparability among the trials in the use of other measures of pain and function, or the more generic self-reporting scales such as the WOMAC.
Quality of the evidence
As shown in the risk of bias summary (Figure 1 ), all five trials were at high of bias in least one domain, which was invariably performance bias reflecting the lack of blinding in those applying the taping and, generally, the trial participants. Poorly described or conducted randomisation, with insufficient attention to ensuring allocation concealment put three trial at high risk of selection bias. Assessor blinding, which should be possible for at least some outcomes, was not done in two studies. Unit of analysis problems, through the inclusion of patients with problems in both knees, and the incomplete information on loss to follow-up were also sources of bias. The quality of the evidence was also hampered by small sample sizes. Overall, the quality of the evidence, using the GRADE terminology, lies between 'Low quality' ("Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate") and 'Very low quality' ("We are very uncertain about the estimate").
Potential biases in the review process
Aside from the changes, which included incorporating updated methodology described in Differences between protocol and review, this review was conducted in accordance with our previously published protocol. We took care to search extensively for studies which were in abstract form but might have proceeded to full publication. We also made great efforts (and were generally successful) to contact authors of studies which were unpublished or were uncompleted trials to ascertain whether their data could be included. Several authors confirmed points for clarification and sent additional data; most of these trials were eventually considered to be ineligible because they did not answer our research question.
Agreements and disagreements with other studies or reviews
Another review in this area has looked at the immediate (very short term effect) of patellar taping (and bracing) on knee pain with and without knee osteoarthritis (Warden 2008 
A U T H O R S ' C O N C L U S I O N S Implications for practice
Patellar taping is a relatively inexpensive and regularly used treatment intervention for patellofemoral pain syndrome. It is frequently used as part of an exercise and rehabilitation programme for this condition. However, the currently available evidence from trials reporting clinically relevant outcomes is low quality and insufficient to draw conclusions on the effects of taping, whether used on its own or as part of a treatment programme.
Implications for research
Although the exact mechanism of patellar taping for the treatment of patellofemoral pain syndrome is unclear, it remains an attractive intervention in terms of application and potential. The low quality clinical evidence available so far does not endorse patellar taping, showing minimal evidence of any effect. It is thus timely that clinicians' enthusiasm for this intervention should be put to the test by conducting large, preferably multi-centre, good quality and well reported randomised controlled trials that measure clinically important outcomes and long-term results. Before this, consensus is required on the diagnosis of patellofemoral pain syndrome, including the avoidance of including patients with osteoarthritis, the standardisation of outcome measurement and an acceptable approach for patellar taping. Some promising progress has been made in this regard in terms of terminology, including shifting away from labelling this condition as a syndrome (Ghent 2011). These are likely to enhance the successful initiation and conduct of such trials and the acceptability and applicability of their findings.
C H A R A C T E R I S T I C S O F S T U D I E S Characteristics of included studies [ordered by study ID]
Clark 2000a
Methods
Observer blinded, randomised controlled trial. 
Clark 2000a (Continued)
Bias
Authors' judgement Support for judgement
Random sequence generation (selection bias)
Low risk "The patients were then randomly allocated by the physiotherapist to one of four groups using an individualised computer generated randomisation programme."
Allocation concealment (selection bias) Unclear risk Use of "individualised computer generated randomisation programme", but insufficient description of method to ensure allocation concealment
Blinding of participants and personnel (performance bias) All outcomes High risk Participants: not done. Therapists: not stated and unlikely due to nature of the treatments Blinding of outcome assessment (detection bias) All outcomes
Low risk "A blinded independent observer undertook the assessment on the sixth visit."
Incomplete outcome data (attrition bias) All outcomes
Low risk "10 patients withdrew from the study and these were included on an intention to treat basis." Participant flow provided
Other bias Unclear risk Baseline characteristics of the four groups were comparable. "All four groups received the same advice. " but lack of information on duration of treatment sessions Diary sheets given to help compliance in exercise groups.
Kowall 1996
Methods Randomised study Participants USA 25 participants (8 male), 10 of whom had bilateral complaints (35 knees). Mean age 29 years (range 14 to 40 years). Duration of symptoms: 2.5 years (range 1 month to 15 years) Inclusion criteria: unilateral or bilateral patellofemoral pain for more than 1 month, patient age between 14 and 40 years, ability to complete a 4-week formal physical therapy programme, and ability to comply with a 4-week home exercise programme. Details of co-interventions Education: all trial participants received an overview of knee anatomy and function, and advice on avoiding painful activities In the second week, all participants received a composite intervention of patellar taping, and quadriceps strengthening and stretching exercises Outcomes Measured at baseline and at weeks 1( post 'singular' intervention) and 2 week (post 'combined' interventions (taping, quadriceps strengthening and stretching)). Only week 1 data considered in review VAS pain scores for 4 activities: ascent of 7 stairs without support; descent of 7 stairs without support; 18 cm step down leading with non-injured leg; and a self selected activity Quadriceps strength isokinetic peak torque at 60º/sec Quadriceps tightness (length), prone lying heel to buttock distance with tape measure Pain free eccentric knee angle control test.
Notes
Data from the two other groups of this trial are not included in this review. One excluded group (15 knees) was given quadriceps strengthening with end range open chain knee extension; and the other group (15 knees) was given quadriceps stretching to rectus femoris in position individualised to each patient Random group allocation was performed and allocation concealment maintained by an independent person overseeing a sealed envelope method Patients completed a daily exercise compliance diary.
Risk of bias
Bias
Authors' judgement Support for judgement Mason 2011 (Continued)
Low risk Participants were "randomly allocated to one of four groups according to a selected, sealed and pre-numbered envelope". (Details of sequence generation were, however, missing.)
Allocation concealment (selection bias) Low risk "sealed and pre-numbered envelope". Not described in text but clarified as being conducted by an independent person by the lead author through personal communication (see Notes above)
Blinding of participants and personnel (performance bias) All outcomes High risk Participants: not possible due to the nature of the interventions. Therapists: the treating therapist was not blinded to the treatment grouping of the subjects Blinding of outcome assessment (detection bias) All outcomes
Low risk Strategies to maintain assessor blinding described as: "All subjects were asked to wear long pants for the end of the first week assessment so that the assessing physiotherapist remained blinded towards the single modality treatment during that week." 
Risk of bias
Bias
Authors' judgement Support for judgement
Unclear risk "A prospective randomized study was designed ..." "The patients were divided into 4 groups matched for age and gender ....". No details of how randomised Allocation concealment (selection bias) High risk Not described, but use of "matching" is of concern.
Blinding of participants and personnel (performance bias) All outcomes Low risk "A block randomisation process was used, where subjects randomly chose 1 of 3 labelled envelopes to determine their group allocation. The next subject chose 1 of the remaining 2 envelopes and the third person was then assigned to the remaining group before the process was repeated. This ensured that there were even numbers of subjects in each group."
Allocation concealment (selection bias) High risk As described above. The allocation was not concealed for every third patient
Blinding of participants and personnel (performance bias) All outcomes High risk Participants: not possible due to the nature of the interventions Therapists: the treating therapist, "who was aware of group allocation, applied adhesive tape to the affected knee of subjects in the taping group and placebo taping group"
Blinding of outcome assessment (detection bias) All outcomes
Low risk
The assessor, who was blinded to group allocation, took all outcome measures
Low risk "All subjects remained in the group to which they were originally assigned."
Other bias Low risk Baseline characteristics comparable in the three groups. "All subjects were placed on restricted duties (similar for all individuals) throughout the treatment period." Every participant attended daily at the same time for 4 weeks duration of the study (study was in a military setting) No home exercise programme prescribed and exercise compliance not needed 
Characteristics of excluded studies
